Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection - PubMed (original) (raw)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
Jeroen N Stoop et al. Hepatology. 2005 Apr.
Abstract
Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to HBV. Regulatory T cells (T(reg)) can suppress the function of effector T cells and may thus be key players in this impaired immune response. Changes in the functionality or number of T(reg) could explain the decreased antiviral response in chronic HBV patients. To investigate the role of T(reg) in chronic HBV infection, we compared the proportional frequency and functionality of T(reg) in peripheral blood of 50 chronic HBV patients, 23 healthy controls, and 9 individuals with a resolved HBV infection. A higher percentage of T(reg), defined as CD4, CD25, CD45RO, and cytotoxic T-lymphocyte-associated antigen 4-positive cells, was detected within the population of CD4(+) cells in peripheral blood of chronic HBV patients compared with healthy controls and individuals with a resolved HBV infection. Accordingly, chronic HBV patients displayed a higher FoxP3 messenger RNA level than healthy controls. Depletion of CD25(+) cells from peripheral blood mononuclear cells (PBMC) of chronic HBV patients resulted in an enhanced proliferation after stimulation with HBV core antigen. Reconstitution of these depleted PBMC with CD4(+)CD25(+) T(reg) resulted in a dose-dependent reduction of both HBV-specific proliferation and interferon gamma production. In conclusion, chronic HBV patients harbor an increased percentage of T(reg) in peripheral blood compared with controls. T(reg) have an immunosuppressive effect on HBV-specific T helper cells. The presence of HBV-specific T(reg) could contribute to an inadequate immune response against the virus, leading to chronic infection.
Comment in
- Regulatory T cells and the liver: a new piece of the puzzle.
Chang KM. Chang KM. Hepatology. 2005 Apr;41(4):700-2. doi: 10.1002/hep.20678. Hepatology. 2005. PMID: 15789365 Review. No abstract available.
Similar articles
- Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V. Rico MA, et al. Hepatology. 2001 Jan;33(1):295-300. doi: 10.1053/jhep.2001.21147. Hepatology. 2001. PMID: 11124848 - Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
Kondo Y, Ueno Y, Kobayashi K, Kakazu E, Shiina M, Inoue J, Tamai K, Wakui Y, Tanaka Y, Ninomiya M, Obara N, Fukushima K, Ishii M, Kobayashi T, Niitsuma H, Kon S, Shimosegawa T. Kondo Y, et al. J Infect Dis. 2010 Jul 15;202(2):202-13. doi: 10.1086/653496. J Infect Dis. 2010. PMID: 20533879 - HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
Feng IC, Koay LB, Sheu MJ, Kuo HT, Sun CS, Lee C, Chuang WL, Liao SK, Wang SL, Tang LY, Cheng CJ, Tsai SL. Feng IC, et al. J Biomed Sci. 2007 Jan;14(1):43-57. doi: 10.1007/s11373-006-9129-z. Epub 2006 Nov 16. J Biomed Sci. 2007. PMID: 17109186 Clinical Trial. - CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A, Beissert S, Krammer PH. Kuhn A, et al. Arch Dermatol Res. 2009 Jan;301(1):71-81. doi: 10.1007/s00403-008-0891-9. Epub 2008 Nov 5. Arch Dermatol Res. 2009. PMID: 18985367 Review. - The immunopathogenesis of HBV infection.
Koziel MJ. Koziel MJ. Antivir Ther. 1998;3(Suppl 3):13-24. Antivir Ther. 1998. PMID: 10726052 Review.
Cited by
- CX3CL1/Fractalkine: A Potential Biomarker for Liver Fibrosis in Chronic HBV Infection.
Arsentieva NA, Korobova ZR, Batsunov OK, Lyubimova NE, Basina VV, Esaulenko EV, Totolian AA. Arsentieva NA, et al. Curr Issues Mol Biol. 2024 Sep 10;46(9):9948-9957. doi: 10.3390/cimb46090593. Curr Issues Mol Biol. 2024. PMID: 39329945 Free PMC article. - CD40 stimulation activates CD8+ T cells and controls HBV in CD4-depleted mice.
Bailey JT, Cangialosi S, Moshkani S, Rexhouse C, Cimino JL, Robek MD. Bailey JT, et al. JHEP Rep. 2024 May 21;6(9):101121. doi: 10.1016/j.jhepr.2024.101121. eCollection 2024 Sep. JHEP Rep. 2024. PMID: 39282227 Free PMC article. - Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.
Costa JP, de Carvalho A, Paiva A, Borges O. Costa JP, et al. Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964. Pharmaceuticals (Basel). 2024. PMID: 39065812 Free PMC article. Review. - mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review.
Boretti A. Boretti A. Clin Exp Med. 2024 Jan 27;24(1):23. doi: 10.1007/s10238-023-01264-1. Clin Exp Med. 2024. PMID: 38280109 Free PMC article. Review. - lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma.
Pehlivanoglu B, Aysal A, Agalar C, Egeli T, Ozbilgin M, Unek T, Unek IT, Oztop I, Aktas S, Sagol O. Pehlivanoglu B, et al. Turk Patoloji Derg. 2024;40(2):101-108. doi: 10.5146/tjpath.2023.13161. Turk Patoloji Derg. 2024. PMID: 38265097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials